GE HealthCare Technologies Inc. (NASDAQ:GEHC) Is Largely Controlled by Institutional Shareholders Who Own 81% of the Company
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Is Largely Controlled by Institutional Shareholders Who Own 81% of the Company
Key Insights
主要見解
- Significantly high institutional ownership implies GE HealthCare Technologies' stock price is sensitive to their trading actions
- 51% of the business is held by the top 11 shareholders
- Recent sales by insiders
- 顯著較高的機構持股意味着GE HealthCare Technologies的股票價格對他們的交易行爲敏感。
- 企業前11大股東持有其51%的股份。
- 最近由內部人士出售。
To get a sense of who is truly in control of GE HealthCare Technologies Inc. (NASDAQ:GEHC), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are institutions with 81% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
要了解誰真正控制GE HealthCare Technologies Inc.(納斯達克:GEHC),重要的是要理解該業務的所有權結構。而持有最大份額的集團是機構,擁有81%的股份。換句話說,這個集團將因其對公司的投資而獲得最多的收益(或承受最多的損失)。
Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.
因爲機構所有者擁有龐大的資源和流動性,他們的投資決策往往帶有很大的分量,尤其是對於個人投資者來說。因此,機構投資在一家公司中的大量資金通常被視爲一個積極因素。
Let's delve deeper into each type of owner of GE HealthCare Technologies, beginning with the chart below.
讓我們深入了解GE醫療科技的每種所有者類型,從下面的圖表開始。
What Does The Institutional Ownership Tell Us About GE HealthCare Technologies?
機構投資者擁有公司的50%以上的股權,因此他們一起可能會對董事會的決策產生很強的影響。GE HealthCare Technologies不屬於對沖基金的所有基金類型。目前,Capital Research and Management Company是最大的股東,持有12%的流通股。相比之下,第二和第三大股東持有約11%和6.8%的股票。
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。
As you can see, institutional investors have a fair amount of stake in GE HealthCare Technologies. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see GE HealthCare Technologies' historic earnings and revenue below, but keep in mind there's always more to the story.
正如你所看到的,機構投資者在GE醫療科技中擁有相當的股份。這意味着爲這些機構工作的分析師已經關注這隻股票,並且對它有好感。但和其他人一樣,他們也可能是錯的。當多家機構同時擁有一隻股票時,總是存在「擁擠交易」的風險。當這種交易出現問題時,多方可能會競爭快速賣出股票。在沒有增長曆史的公司中,這種風險更高。你可以在下面看到GE醫療科技的歷史收益和營業收入,但請記住,事情總是還有更深層次的故事。
Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. We note that hedge funds don't have a meaningful investment in GE HealthCare Technologies. Capital Research and Management Company is currently the company's largest shareholder with 13% of shares outstanding. In comparison, the second and third largest shareholders hold about 11% and 7.9% of the stock.
投資者應注意,機構實際上擁有公司一半以上的股份,因此他們可以集體發揮顯著的影響力。我們注意到對GE健康科技的對沖基金沒有做出重大投資。資本研究與管理公司目前是公司的最大股東,持有13%的流通股票。相比之下,第二和第三大股東分別持有約11%和7.9%的股票。
After doing some more digging, we found that the top 11 have the combined ownership of 51% in the company, suggesting that no single shareholder has significant control over the company.
經過更深入的了解,我們發現前11名在該公司擁有51%的所有權,表明沒有單一的股東對公司擁有重要的控制權。
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
研究機構持股比例是衡量和篩選股票預期表現的好方法。同樣可以通過研究分析師情緒來實現。由於相當多的分析師都關注着該股票,因此你可以很容易地研究預測的增長。
Insider Ownership Of GE HealthCare Technologies
GE HealthCare Technologies的內部所有權
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
內部人員的定義在不同國家可能會稍有不同,但董事會成員始終算入其中。公司管理負責經營業務,但即使首席執行官是董事會成員,他或她也必須對董事會負責。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
當內部人持股情況表明領導層思考和公司真正所有者一樣時,內部所有權是積極的。然而,高達內部人士所有權也可能爲公司內的小團體帶來巨大的權力。在某些情況下,這可能是負面的。
Our information suggests that GE HealthCare Technologies Inc. insiders own under 1% of the company. Being so large, we would not expect insiders to own a large proportion of the stock. Collectively, they own US$51m of stock. It is always good to see at least some insider ownership, but it might be worth checking if those insiders have been selling.
我們的信息顯示,通用電氣醫療科技公司內部人士持有不到1%的股份。由於公司規模如此之大,我們不指望內部人士擁有大量股票。總體來看,他們持有價值5100萬美元的股票。看到一些內部人士的持股總是好事,但值得檢查一下這些內部人士是否有在賣出。
General Public Ownership
一般大衆所有權
With a 15% ownership, the general public, mostly comprising of individual investors, have some degree of sway over GE HealthCare Technologies. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
公衆持有15%的股份,主要由個人投資者組成,對通用電氣醫療科技公司有一定程度的影響。雖然這個群體不一定能夠做主,但他們確實能對公司的運行產生真實的影響。
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - GE HealthCare Technologies has 1 warning sign we think you should be aware of.
我發現查看公司真正的所有者非常有趣。但要真正獲得深入見解,我們還需要考慮其他信息。例如,風險 - 通用電氣醫療科技有一個我們認爲你應該注意的警告信號。
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
如果您像我一樣,可能希望考慮這家公司是否會增長或縮小。幸運的是,您可以查看此免費報告,顯示分析師對其未來的預測。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。
譯文內容由第三人軟體翻譯。